JP2015010082A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015010082A5 JP2015010082A5 JP2013138884A JP2013138884A JP2015010082A5 JP 2015010082 A5 JP2015010082 A5 JP 2015010082A5 JP 2013138884 A JP2013138884 A JP 2013138884A JP 2013138884 A JP2013138884 A JP 2013138884A JP 2015010082 A5 JP2015010082 A5 JP 2015010082A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen atom
- alkyl group
- carbon atoms
- carbon
- bonded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000004432 carbon atom Chemical group C* 0.000 claims 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 230000007794 irritation Effects 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 101000764872 Homo sapiens Transient receptor potential cation channel subfamily A member 1 Proteins 0.000 claims 1
- 102100026186 Transient receptor potential cation channel subfamily A member 1 Human genes 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 claims 1
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 230000002421 anti-septic effect Effects 0.000 claims 1
- 229940064004 antiseptic throat preparations Drugs 0.000 claims 1
- 239000003638 chemical reducing agent Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 210000004400 mucous membrane Anatomy 0.000 claims 1
- 231100000017 mucous membrane irritation Toxicity 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000035807 sensation Effects 0.000 claims 1
- 230000035909 sensory irritation Effects 0.000 claims 1
- 231100000475 skin irritation Toxicity 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013138884A JP5789642B2 (ja) | 2013-07-02 | 2013-07-02 | 刺激感緩和剤 |
| PCT/JP2014/067213 WO2015002095A1 (ja) | 2013-07-02 | 2014-06-27 | 刺激感緩和剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013138884A JP5789642B2 (ja) | 2013-07-02 | 2013-07-02 | 刺激感緩和剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015010082A JP2015010082A (ja) | 2015-01-19 |
| JP2015010082A5 true JP2015010082A5 (enrdf_load_stackoverflow) | 2015-04-16 |
| JP5789642B2 JP5789642B2 (ja) | 2015-10-07 |
Family
ID=52143673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013138884A Active JP5789642B2 (ja) | 2013-07-02 | 2013-07-02 | 刺激感緩和剤 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP5789642B2 (enrdf_load_stackoverflow) |
| WO (1) | WO2015002095A1 (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3114235A1 (fr) | 2020-09-18 | 2022-03-25 | Université Grenoble Alpes | Inhibition du canal trpa1 astrocytaire comme nouvelle cible therapeutique neuroprotectrice dans les phases prodromales de la maladie d’alzheimer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4070374A (en) * | 1975-06-16 | 1978-01-24 | Givaudan Corporation | Process for the preparation of aryl substituted aldehydes, ketones and alcohols |
| JPS6456635A (en) * | 1987-08-25 | 1989-03-03 | Kao Corp | 2,2,4-trimethyl-1-phenyl-3-pentanol and perfume composition containing said compound |
| US6086903A (en) * | 1996-02-26 | 2000-07-11 | The Proctor & Gamble Company | Personal treatment compositions and/or cosmetic compositions containing enduring perfume |
| JP2002121152A (ja) * | 2000-10-13 | 2002-04-23 | Chugai Pharmaceut Co Ltd | 外用消炎鎮痛剤 |
| DE10330697A1 (de) * | 2003-07-08 | 2005-02-03 | Symrise Gmbh & Co. Kg | Sekundäre Alkohole als antimikrobielle Wirkstoffe |
| US8754028B2 (en) * | 2008-12-16 | 2014-06-17 | The Procter & Gamble Company | Perfume systems |
| US20130315843A1 (en) * | 2012-05-25 | 2013-11-28 | The Procter & Gamble Company | Composition for reduction of trpa1 and trpv1 sensations |
-
2013
- 2013-07-02 JP JP2013138884A patent/JP5789642B2/ja active Active
-
2014
- 2014-06-27 WO PCT/JP2014/067213 patent/WO2015002095A1/ja active Application Filing
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20192202T1 (hr) | Acc inhibitori i njihove upotrebe | |
| CA2894892A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| PH12015501412A1 (en) | SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND MEDICINAL USE THEREOF AS HIV INTEGRASE INHIBITOR | |
| EA201390885A1 (ru) | Азаиндолы в качестве противовирусных агентов против респираторного синцитиального вируса | |
| JP2015078230A5 (enrdf_load_stackoverflow) | ||
| HRP20171648T1 (hr) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| JP2011527299A5 (enrdf_load_stackoverflow) | ||
| CA2864098A1 (en) | Spiro[2.4]heptanes for treatment of flaviviridae infections | |
| WO2014060638A8 (en) | A veterinary method of alleviating noise aversion | |
| PH12014502743A1 (en) | Carbamate/urea derivatives | |
| JP2016515550A5 (enrdf_load_stackoverflow) | ||
| MX2016001422A (es) | Composicion farmaceutica de fingolimod. | |
| CA2922375C (en) | Alpha-tea salt forms: compositions and uses for treating disease | |
| PH12013500371A1 (en) | Therapeutic agent for pain | |
| JP2014080432A5 (enrdf_load_stackoverflow) | ||
| JP2018199643A5 (enrdf_load_stackoverflow) | ||
| JP2017513944A5 (enrdf_load_stackoverflow) | ||
| JP2013071928A5 (enrdf_load_stackoverflow) | ||
| JP2015010082A5 (enrdf_load_stackoverflow) | ||
| MY197518A (en) | Preventive and/or therapeutic agent of immune disease | |
| JP2018150270A5 (enrdf_load_stackoverflow) | ||
| JP2014526571A5 (enrdf_load_stackoverflow) | ||
| JP2013256473A5 (enrdf_load_stackoverflow) | ||
| RU2015141335A (ru) | 2β,3α,5α-ТРИГИДРОКСИ-АНДРОСТ-6-ОН, СПОСОБЫ ЕГО ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ | |
| JP2015214533A5 (enrdf_load_stackoverflow) |